# Ibere Pharmaceuticals (IBER)

Source: https://www.quantisnow.com/company/IBER
Generated: 2026-11-11T06:47:51.500Z

- Ticker: IBER
- Exchange: NYSE
- Sector: Finance
- Industry: Blank Checks
- IPO year: 2021

## About

Ibere Pharmaceuticals focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in Philadelphia, Pennsylvania.

## Latest IBER news and filings

- 2023-03-13 15:00 UTC [SEC Form 15-12G filed by Ibere Pharmaceuticals](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-ibere-pharmaceuticals-4192234)
- 2023-03-02 17:08 UTC [SEC Form 25-NSE filed by Ibere Pharmaceuticals](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-ibere-pharmaceuticals-4152498)
- 2023-02-15 15:42 UTC [SEC Form 8-K] [Ibere Pharmaceuticals filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/ibere-pharmaceuticals-filed-sec-form-8-k-other-events-financial-statements-4070011)
- 2023-02-15 15:36 UTC [Market Insight] [Ibere Pharmaceuticals Will Redeem All Outstanding Ordinary Shares Included In Units Issued In IPO Effective As Of Close Of Business On March 2; Per-Share Redemption Price For Public Shares Will Be ~$10.17;  Expects That NYSE Will File Form 25 To Delist Co](https://www.quantisnow.com/insight/ibere-pharmaceuticals-will-redeem-all-outstanding-ordinary-shares-included-in-4069964)
- 2023-02-14 17:36 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Ibere Pharmaceuticals](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-ibere-pharmaceuticals-4059373)
- 2023-02-14 13:14 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Ibere Pharmaceuticals (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-ibere-pharmaceuticals-amendment-4055184)
- 2023-02-08 20:19 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Ibere Pharmaceuticals](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-ibere-pharmaceuticals-4024320)
- 2023-02-08 19:09 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Ibere Pharmaceuticals (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-ibere-pharmaceuticals-amendment-4023979)
- 2023-02-02 16:10 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Ibere Pharmaceuticals (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-ibere-pharmaceuticals-amendment-3994512)
- 2022-11-14 20:48 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Ibere Pharmaceuticals](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-ibere-pharmaceuticals-3680878)
- 2022-08-12 20:13 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Ibere Pharmaceuticals](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-ibere-pharmaceuticals-3280199)
- 2022-05-16 17:42 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Ibere Pharmaceuticals](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-ibere-pharmaceuticals-2894120)
- 2022-03-31 20:48 UTC [SEC Form 10-K] [SEC Form 10-K filed by Ibere Pharmaceuticals](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-ibere-pharmaceuticals-2659969)
- 2022-02-14 11:12 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Ibere Pharmaceuticals (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-ibere-pharmaceuticals-amendment-2404374)
- 2022-02-08 21:23 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Ibere Pharmaceuticals](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-ibere-pharmaceuticals-2373914)
- 2022-01-14 18:43 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Ibere Pharmaceuticals](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-ibere-pharmaceuticals-2257497)
- 2021-11-12 20:28 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Ibere Pharmaceuticals](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-ibere-pharmaceuticals-2002234)
- 2021-09-27 18:36 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Ibere Pharmaceuticals](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-ibere-pharmaceuticals-1812745)
- 2021-08-16 21:21 UTC [SEC Form 10-Q] [SEC Form 10-Q/A filed by Ibere Pharmaceuticals (Amendment)](https://www.quantisnow.com/insight/sec-form-10-qa-filed-by-ibere-pharmaceuticals-amendment-1675045)
- 2021-08-16 21:24 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Ibere Pharmaceuticals](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-ibere-pharmaceuticals-1675020)
- 2021-08-16 21:12 UTC [SEC Form 8-K] [SEC Form 8-K/A filed by Ibere Pharmaceuticals (Amendment)](https://www.quantisnow.com/insight/sec-form-8-ka-filed-by-ibere-pharmaceuticals-amendment-1674906)
- 2021-08-13 18:53 UTC [SEC Form 8-K] [Ibere Pharmaceuticals filed SEC Form 8-K: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review](https://www.quantisnow.com/insight/ibere-pharmaceuticals-filed-sec-form-8-k-non-reliance-on-previously-issued-1668152)
- 2021-08-04 18:09 UTC [SEC Form 8-K] [Ibere Pharmaceuticals filed SEC Form 8-K: Changes in Registrant’s Certifying Accountant, Financial Statements and Exhibits](https://www.quantisnow.com/insight/ibere-pharmaceuticals-filed-sec-form-8-k-changes-in-registrants-certifying-1624436)
- 2021-07-16 19:21 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Ibere Pharmaceuticals](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-ibere-pharmaceuticals-1398146)
- 2021-05-28 22:00 UTC [Public Offering] [Ibere Pharmaceuticals Receives Expected NYSE Notice Regarding Delayed Quarterly Report](https://www.quantisnow.com/insight/ibere-pharmaceuticals-receives-expected-nyse-notice-regarding-delayed-quarterly-report-902161)
- 2021-05-28 21:25 UTC [SEC Form 8-K] [SEC Form 8-K filed by Ibere Pharmaceuticals](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-ibere-pharmaceuticals-901743)
- 2021-05-18 13:03 UTC [SEC Form NT 10-Q filed by Ibere Pharmaceuticals](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-ibere-pharmaceuticals-755894)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/IBER
- Earnings history: https://www.quantisnow.com/earnings/IBER
- Dividend history: https://www.quantisnow.com/dividends/IBER
- Insider transactions: https://www.quantisnow.com/insiders/IBER
- Options chain: https://www.quantisnow.com/options/IBER
- SEC 8-K filings only: https://www.quantisnow.com/company/IBER/8-k
- RSS and alerts for IBER: https://www.quantisnow.com/docs/rss-feeds.md